These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5699090)

  • 1. Pharmacologic potency and selectivity of a new bronchodilator agent: soterenol (MJ 1992).
    Dungan KW; Cho YW; Gomoll AW; Aviado DM; Lish PM
    J Pharmacol Exp Ther; 1968 Dec; 164(2):290-301. PubMed ID: 5699090
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacodynamics of a new selective beta2-adrenergic bronchodilator 3-(4-methoxybenzylamino)-4-hydroxy-alpha-(tert. butylaminomethyl)-benzyl-alcohol, HCl (QH25).
    Larsen JJ; Hermansen K
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40(1):42-64. PubMed ID: 576362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative beta-adrenoceptive stimulant properties of salbutamol (AH 3365), orciprenaline and soterenol (MJ 1992).
    Farmer JB; Levy GP
    Br J Pharmacol; 1969 Feb; 35(2):P358-9. PubMed ID: 5774057
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of the pharmacology of salbutamol with that of isoprenaline, orciprenaline and trimetoquinol.
    Brittain RT
    Postgrad Med J; 1971 Mar; 47():Suppl:11-6. PubMed ID: 5572509
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the beta-adrenoceptor stimulant properties of salbutamol, orciprenaline and soterenol with those of isoprenaline.
    Farmer JB; Levy GP; Marshall RJ
    J Pharm Pharmacol; 1970 Dec; 22(12):945-7. PubMed ID: 4395522
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacodynamic study of a new antiasthmatic drug. Salbutamol].
    Foussard-Blanpin O; Narcisse G
    Therapie; 1971; 26(6):1081-96. PubMed ID: 4401716
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanism of action of bronchodilators].
    Yanaura S; Ishizaki M; Ishikawa S; Motoashi Y
    Nihon Yakurigaku Zasshi; 1973 Mar; 69(2):249-56. PubMed ID: 4807877
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular effects of salbutamol: a comparison with isoprenaline.
    Coleman AJ; Leary WP
    S Afr Med J; 1972 Aug; 46(33):1177-9. PubMed ID: 5079697
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on carbuterol (SK & F 40383-A), a new selective bronchodilator agent.
    Wardell JR; Colella DF; Shetzline A; Fowler PJ
    J Pharmacol Exp Ther; 1974 Apr; 189(1):167-84. PubMed ID: 4823290
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha-[(t-Butylamino)methyl]-4-hydroxy-m-xylene-alpha 1,alpha 3-diol (AH.3365): a selective beta-adrenergic stimulant.
    Brittain RT; Farmer JB; Jack D; Martin LE; Simpson WT
    Nature; 1968 Aug; 219(5156):862-3. PubMed ID: 5673352
    [No Abstract]   [Full Text] [Related]  

  • 11. 3-(Alpha-(tert-butylamino)methyl)-5-hydroxy-m-xylene-alpha, alpha'-diol, a selective bronchodilator.
    Schwender CF; Sunday BR; Shavel J
    J Med Chem; 1974 Oct; 17(10):1112-5. PubMed ID: 4153860
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanism of action of bronchodilators].
    Takumi Y; Noguchi H; Miyano H; Aochi O
    Masui; 1970 Nov; 19(12):1355-63. PubMed ID: 5530217
    [No Abstract]   [Full Text] [Related]  

  • 13. Bronchodilatory and cardiovascular effects of metaproterenol.
    Diamond L
    J Pharm Sci; 1968 Jun; 57(6):971-5. PubMed ID: 4876453
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological studies of trans-6-hydroxy-5-hydroxymethyl-2-isopropylamino-1,2,3,4,-tetrahydro-1-naphthalenol hydrochloride (AA-497), a new potent bronchodilator.
    Inatomi N; Kuriki H; Kanno M; Kawazoe K; Nagawa Y; Miyata T; Takahama K; Kasé Y
    Arzneimittelforschung; 1980; 30(2):276-85. PubMed ID: 7378107
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the bronchodilator activities of isoproterenol and of prostaglandin E 1 aerosols.
    Adolphson RL; Townley RG
    Chest; 1973 Apr; 63():Suppl:5S-6S. PubMed ID: 4633063
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of beta-sympathomimetics and sympatholytics on renal function in dogs].
    Heidenreich O; Fülgraff G; Laaff H; Balshüsemann E
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(3):439-49. PubMed ID: 5797626
    [No Abstract]   [Full Text] [Related]  

  • 17. Bronchodilator substances. Part II: experimental study of a new antiasthmatic drug, S 1688, without beta-stimulant properties.
    Duhault JL; Tisserand FP; Regnier GL
    Arzneimittelforschung; 1974 Dec; 24(12):1970-4. PubMed ID: 4480359
    [No Abstract]   [Full Text] [Related]  

  • 18. [Body plethysmographic and blood gas-analytical clinico-experimental study on a new bronchospasmolytic drug hexoprenaline].
    Schindl R
    Arzneimittelforschung; 1970 Nov; 20(11):1755-63. PubMed ID: 5536986
    [No Abstract]   [Full Text] [Related]  

  • 19. Utilization of changes in pulmonary resistance for the evaluation of bronchodilator drugs.
    Diamond L
    Arch Int Pharmacodyn Ther; 1967 Jul; 168(1):239-50. PubMed ID: 6048729
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular effects of AH.3365 (salbutamol).
    Kelman GR; Palmer KN; Cross MR
    Nature; 1969 Mar; 221(5187):1251. PubMed ID: 4886589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.